In Brief: PharmaPrint
This article was originally published in The Tan Sheet
Executive Summary
PharmaPrint: Michael Tempesta, PhD, to senior VP-research, the Irvine, Calif.-based herbal medicine developer and marketer announces. Tempesta previously served as president of NatProd Consulting services and as chief scientific officer for both Larex, Inc. and San Francisco-based Shaman Pharmaceuticals. PharmaPrint also promotes President and CEO Elliot Friedman to chairman; Exec VP and Chief Operating Officer Robert Burgess is named president...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning